Literature DB >> 22229731

A novel mutation W388X underlying properdin deficiency in a Finnish family.

M Helminen1, S Seitsonen, H Jarva, S Meri, I E Järvelä.   

Abstract

Properdin deficiency is a rare immunological disorder inherited as an X-chromosomal recessive trait. Properdin deficiency poses a significant risk for severe meningococcal infections. About 20 mutations have been reported to underlie properdin deficiency. Here we report a large Finnish family with a novel mutation in the properdin gene (CFP). Based on the total absence of properdin activity in a 14-year-old male patient with an infection resembling meningococcal bacteraemia, the coding region and splice sites of the gene were sequenced. The mutation is located in exon 9 and changes guanine to adenine at nucleotide 1164 (c.1164G>A) that causes tryptophan to change to a premature stop codon (W388X). The mother of the patient was shown to be a carrier of the mutation. In total, the mutation was identified in six females and three young males in the family. The mutation must be inherited from the grandfather who had died of an unknown infectious disease. This is the first mutation of the properdin gene identified in Finland.
© 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22229731      PMCID: PMC3306489          DOI: 10.1111/j.1365-3083.2012.02674.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  19 in total

Review 1.  Complement and properidin deficiencies in meningococcal disease.

Authors:  Susan Mathew; Gary D Overturf
Journal:  Pediatr Infect Dis J       Date:  2006-03       Impact factor: 2.129

2.  Linkage analysis of the properdin deficiency gene: suggestion of a locus in the proximal part of the short arm of the X chromosome.

Authors:  P Goonewardena; A G Sjöholm; L A Nilsson; U Pettersson
Journal:  Genomics       Date:  1988-02       Impact factor: 5.736

Review 3.  Human properdin deficiency has a heterogeneous genetic background.

Authors:  L Truedsson; J Westberg; G N Fredrikson; A G Sjöholm; E J Kuijper; C A Fijen; P J Späth; M Uhlén
Journal:  Immunopharmacology       Date:  1997-12

4.  Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange.

Authors:  G N Fredrikson; J Westberg; E J Kuijper; C C Tijssen; A G Sjöholm; M Uhlén; L Truedsson
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

5.  Properdin deficiency in a family with fulminant meningococcal infections.

Authors:  A G Sjöholm; J H Braconier; C Söderström
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

6.  Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis.

Authors:  Lise Bathum; Heidi Hansen; Børge Teisner; Claus Koch; Peter Garred; Kirsten Rasmussen; Palle Wang
Journal:  Mol Immunol       Date:  2005-03-21       Impact factor: 4.407

Review 7.  Complement deficiency and disease: an update.

Authors:  A G Sjöholm; G Jönsson; J H Braconier; G Sturfelt; L Truedsson
Journal:  Mol Immunol       Date:  2006-01       Impact factor: 4.407

8.  Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood.

Authors:  Joerg Faber; Therese Schuessler; Adam Finn; Craig Murdoch; Werner Zenz; Pirmin Habermehl; Claudius U Meyer; Bernhard U Zabel; Heinz Schmitt; Fred Zepp; Markus Knuf
Journal:  Pediatr Infect Dis J       Date:  2007-03       Impact factor: 2.129

9.  Properdin deficiency associated with recurrent otitis media and pneumonia, and identification of male carrier with Klinefelter syndrome.

Authors:  Lone Schejbel; Vibeke Rosenfeldt; Hanne Marquart; Niels Henrik Valerius; Peter Garred
Journal:  Clin Immunol       Date:  2009-03-27       Impact factor: 3.969

10.  Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection.

Authors:  Mikko Seppänen; Marja-Liisa Lokki; Maija Lappalainen; Eija Hiltunen-Back; Anja T Rovio; Saara Kares; Mikko Hurme; Janne Aittoniemi
Journal:  Hum Immunol       Date:  2009-02-04       Impact factor: 2.850

View more
  4 in total

1.  Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies.

Authors:  Carine El Sissy; Jérémie Rosain; Paula Vieira-Martins; Pauline Bordereau; Aurélia Gruber; Magali Devriese; Loïc de Pontual; Muhamed-Kheir Taha; Claire Fieschi; Capucine Picard; Véronique Frémeaux-Bacchi
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

Review 2.  Human genetics of meningococcal infections.

Authors:  Stephanie Hodeib; Jethro A Herberg; Michael Levin; Vanessa Sancho-Shimizu
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

3.  The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?

Authors:  Marloes A H M Michels; Elena B Volokhina; Nicole C A J van de Kar; Lambertus P W J van den Heuvel
Journal:  Pediatr Nephrol       Date:  2018-08-23       Impact factor: 3.714

4.  European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management.

Authors:  Nicholas Brodszki; Ashley Frazer-Abel; Anete S Grumach; Michael Kirschfink; Jiri Litzman; Elena Perez; Mikko R J Seppänen; Kathleen E Sullivan; Stephen Jolles
Journal:  J Clin Immunol       Date:  2020-02-17       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.